Literature DB >> 33095150

Mediterranean diet and risk of Sjögren's syndrome.

Aleksander Machowicz1, Isaac Hall1, Paola de Pablo2, Saaeha Rauz3, Andrea Richards4, Jon Higham4, Ana Poveda-Gallego5, Fumiaki Imamura6, Simon J Bowman2, Francesca Barone2, Benjamin A Fisher7.   

Abstract

OBJECTIVES: Non-genetic risk factors for Sjögren's syndrome (SS) are poorly understood. Adherence to a Mediterranean diet has been associated with reduction in other autoimmune diseases. We examined the association of Mediterranean diet with SS.
METHODS: New patients attending a single centre warranting investigation for primary SS (pSS) were recruited into the Optimising Assessment in Sjögren's Syndrome cohort established in Birmingham, UK (2014-2018). Participants were classified into pSS and non-SS sicca, considered as cases and non-cases, respectively, and asked to complete an optional food frequency questionnaire on their diet before onset of symptoms. A semi-quantitative Mediterranean diet score (MDS) was calculated (possible range=0 to 18). Using multivariate logistic regression, corrected for energy intake, body-mass index, sex, age, symptom duration, and smoking status, we examined the association of MDS with SS.
RESULTS: Dietary data were available for 133/243 (55%) eligible patients (n=82 pSS and n=51 sicca). In the adjusted model, a higher total MDS (mean ± SD, 9.41±2.31 points) was associated with lower odds of pSS (OR 0.81, 95% CI 0.66-0.99; p=0.038) per one unit of MDS. Among MDS components, the strongest association was seen with fish with OR 0.44 (95% CI 0.24-0.83; p=0.01) in the comparison between <1 portion/week and 1 to 2.5 portions/week. Higher galactose, vitamin A-retinol-equivalents and vitamin C showed associations with lower odds of pSS in multivariate analysis, where the association of vitamin C was attenuated when adjusted for MDS.
CONCLUSIONS: When adjusted for potential confounders, adherence to the Mediterranean diet was associated with lower likelihood of having pSS.

Entities:  

Mesh:

Year:  2020        PMID: 33095150

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  Association between a History of herpes zoster and the risk of Sjögren's syndrome: a nationwide, population-based, case-control study.

Authors:  Pei Ju Huang; Shih-Ping Lin; Chun-Yi Wu; Yen-Tze Liu; Hsin-Hua Chen
Journal:  BMJ Open       Date:  2022-10-14       Impact factor: 3.006

2.  Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases.

Authors:  Ilya Korsunsky; Kevin Wei; Mathilde Pohin; Edy Y Kim; Francesca Barone; Triin Major; Emily Taylor; Rahul Ravindran; Samuel Kemble; Gerald F M Watts; A Helena Jonsson; Yunju Jeong; Humra Athar; Dylan Windell; Joyce B Kang; Matthias Friedrich; Jason Turner; Saba Nayar; Benjamin A Fisher; Karim Raza; Jennifer L Marshall; Adam P Croft; Tomoyoshi Tamura; Lynette M Sholl; Marina Vivero; Ivan O Rosas; Simon J Bowman; Mark Coles; Andreas P Frei; Kara Lassen; Andrew Filer; Fiona Powrie; Christopher D Buckley; Michael B Brenner; Soumya Raychaudhuri
Journal:  Med (N Y)       Date:  2022-05-31

3.  Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature.

Authors:  Valentina Pucino; Jason D Turner; Saba Nayar; Florian Kollert; Saaeha Rauz; Andrea Richards; Jon Higham; Ana Poveda-Gallego; Simon J Bowman; Francesca Barone; Benjamin A Fisher
Journal:  RMD Open       Date:  2022-05

Review 4.  Microbiome and immune-mediated dry eye: a review.

Authors:  Arjun Watane; Shyamal Raolji; Kara Cavuoto; Anat Galor
Journal:  BMJ Open Ophthalmol       Date:  2022-06

5.  How to Measure Adherence to a Mediterranean Diet in Dental Studies: Is a Short Adherence Screener Enough? A Comparative Analysis.

Authors:  Valentin Bartha; Lea Exner; Anna-Lisa Meyer; Maryam Basrai; Daniela Schweikert; Michael Adolph; Thomas Bruckner; Christian Meller; Johan Peter Woelber; Diana Wolff
Journal:  Nutrients       Date:  2022-03-19       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.